R&D Leaders' Forum Autumn 2005

1 post / 0 new
Fraser Moss
Fraser Moss's picture
R&D Leaders' Forum Autumn 2005

The R&D Leaders Forum 2005 will take place from the 5th to the 7th of October at the Maritim ProArte Hotel in Berlin, Germany.

http://www.phacilitate.co.uk/pages/autumn_leaders_2005/index.html

Speaker list

Dr Wolfgang Plischke President Division Pharma, Bayer HealthCare AG
Dr Jan Lundberg Executive Vice President, Global Discovery Research, AstraZeneca AB
Georgette Lalis Director, Consumer Goods, Enterprise & Industry DG, European Commission
Dr Steve Arlington Global Pharmaceuticals Lead, IBM Business Consulting Services
Professor Jackie Hunter Senior Vice President & Head, Neurology & GI Centre of Excellence for Drug Discovery, GlaxoSmithKline
Dr Gerald L. Fisher, PhD Senior Vice President, Office of the President, Wyeth Research
Lawrence J. Lesko, PhD, FCP Director, Office of Clinical Pharmacology & Biopharmaceutics, Center for Drug Evaluation & Research, US Food & Drug Administration
Dr Melanie Lee Executive Vice President, R&D, UCB-Celltech
Dr Douglas Greene Vice President, Corporate Medical & Regulatory Affairs, Sanofi-Aventis
Dr John Stageman Vice President, Global Sciences & Information, AstraZeneca
Jo Walton Managing Director & Research Analyst, Healthcare Research, Lehman Brothers
Dr Abbie C. Celniker Senior Vice President, R&D Strategy & Operations, Millennium Pharmaceuticals, Inc
Dr Alan Houston Executive Vice President, R&D Europe, Astellas Pharma, Inc
Professor Donald R. Stanski Scientific Advisor, Office of the Director, CDER, US Food & Drug Administration, Professor of Anesthesia, Stanford University
Dr Anders Ullman Senior Vice President of R&D & CSO, Biovitrum AB
Professor Martin Schneider Head of Enabling Technologies, Schering AG
Dr Michael Schultz Vice President, Strategic Project Management for Global Pharma Research, Bayer AG
Dr Chris Compton Head of Translational Medicine, Pfizer Global R&D, Sandwich, UK
Dr David J. Mazzo President & CEO, Chugai Pharma USA LLC
Dr Ray Hill Executive Director, Licensing & External Research, Europe, Merck, Sharp & Dohme
Dr Mark A. Labow Executive Director, Functional Genomics, Novartis Institutes for BioMedical Research, Inc
Dr Nicholas Dracopoli Vice President, Clinical Discovery Technologies, Bristol-Myers Squibb Pharmaceutical Research Institute
Dr Christine Cioffe Vice President, R&D Portfolio Management, Merck Research Laboratories
Christine A. Carberry Vice President of Program & Alliance Management, Biogen Idec, Inc
Dr Richard Palmer CEO, Alizyme Therapeutics Ltd
Dr Sarah King Life Sciences/Pharma EMEA R&D Leader, IBM Business Consulting Services
Heinrich Klech, MD, PhD Professor of Medicine, Area Director, Medical & Regulatory, Central/Eastern Europe, Africa, Middle East & CIS Area, Eli Lilly Austria
Professor Ole J. Bjerrum Professor of Pharmacology, The Danish University of Pharmaceutical Science, President, EUFEPS (European Federation of Pharmaceutical Sciences)
Professor Alan Maynard Chair of York Hospitals NHS Trust, Professor, Health Economics & Director, York Health Policy Group, Department of Health Sciences, University of York
Dr Wolfgang Shngen Chief Executive Officer & Founder, PAION AG
Dr Charles T. Gombar Vice President, Project Management, Wyeth Research
Professor Brge Diderichsen Past-President of the European Federation of Biotechnology, Vice President, Corporate Research Affairs, Novo Nordisk A/S
Dr Garth McBride Head, Global R&D Risk Management, Schering AG
Dr David Slavin Global Head of Benefit & Risk Technologies, Pfizer, Inc
Dr Duncan McHale Senior Director, Clinical Pharmacogenetics, Pfizer Global R&D
Dr Helen J. Ambrose Director, R&D Genetics, AstraZeneca
Dr Peter Heinrich CEO & Co Founder, MediGene AG
Dr John Hutchison Development Director, Vernalis
Dr Gerd Maass Director, Biomarker Program - Oncology, Roche Diagnostics GmbH
Dr Iain Cockburn Vice President, Global Pharmacovigilance & Risk Management, Shire Pharmaceuticals Ltd
Dr Oliver Steinbach Head of Department, Technology Management, Altana Pharma
Dr Ulrik Nielsen Vice President of Research, Merrimack Pharmaceuticals

click here to see Agenda